meet the team
that’s changing
the world

One molecule at a time

About The Company

Apton Biosystems, Inc., is a Pleasanton, California-based developer of Super-Res™ sequencing and single molecule detection systems for large-scale clinical applications such as early cancer detection and population sequencing. Apton has re-imagined the optical systems for sequencing using super-resolution to evaluate molecules spaced closer than a wavelength of light. Apton’s Super-Res technology allows us to densely sequence tens of billions of reads in a single run using simple un-patterned flow cells that lower variable costs.


John Hanna


Founder, CTO

Chairman of the Board

Board Member

Jay Kern

Board Member

Board Member